Recent studies have found that the cGAS-STING pathway being activated in the setting of genome instability can be attributed to dMMR 38, PARP inhibitor treatment, or functional loss of BRCA1/2 genes 39, and it predicts a better prognosis of tumor patients. This evidence concerns the gene STING1 and neoplasm.